Joris Braspenning

1.0k total citations
21 papers, 841 citations indexed

About

Joris Braspenning is a scholar working on Epidemiology, Surgery and Molecular Biology. According to data from OpenAlex, Joris Braspenning has authored 21 papers receiving a total of 841 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 5 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in Joris Braspenning's work include Cervical Cancer and HPV Research (6 papers), Liver physiology and pathology (5 papers) and 3D Printing in Biomedical Research (5 papers). Joris Braspenning is often cited by papers focused on Cervical Cancer and HPV Research (6 papers), Liver physiology and pathology (5 papers) and 3D Printing in Biomedical Research (5 papers). Joris Braspenning collaborates with scholars based in Germany, United Kingdom and Italy. Joris Braspenning's co-authors include Stefan Heinz, Lutz Gissmann, Martin Müller, Jian Zhou, Alexander Bürger, Josef Gabelsberger, Heike Walles, Klaus Zumbach, Martin Scheffner and Luis Benı́tez-Bribiesca and has published in prestigious journals such as Nature Biotechnology, PLoS ONE and Oncogene.

In The Last Decade

Joris Braspenning

21 papers receiving 824 citations

Peers

Joris Braspenning

EPIDE

IMMUN

HEPAT

SURGE

Corrine Quirk United States

Martin R. Burda Germany

Dirk Wohlleber Germany

Xiaojun Hu China

Qing Chang China

Francisca Molina‐Jiménez Spain

Maria Teresa Catanese United States

Xianping Liang United States

Gabriella Rizzuto Italy

Corrine Quirk United States

Joris Braspenning

178 ×0.6

EPIDE

168 ×0.7

IMMUN

353 ×1.5

364 ×2.2

HEPAT

228 ×1.4

SURGE

Citations per year, relative to Joris Braspenning Joris Braspenning (= 1×) peers Corrine Quirk

Countries citing papers authored by Joris Braspenning

Since Specialization

Citations

This map shows the geographic impact of Joris Braspenning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joris Braspenning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joris Braspenning more than expected).

Fields of papers citing papers by Joris Braspenning

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joris Braspenning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joris Braspenning. The network helps show where Joris Braspenning may publish in the future.

Co-authorship network of co-authors of Joris Braspenning

This figure shows the co-authorship network connecting the top 25 collaborators of Joris Braspenning. A scholar is included among the top collaborators of Joris Braspenning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joris Braspenning. Joris Braspenning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Olgasi, Cristina, Chiara Borsotti, Simone Merlin, et al.. (2021). Efficient and safe correction of hemophilia A by lentiviral vector-transduced BOECs in an implantable device. Molecular Therapy — Methods & Clinical Development. 23. 551–566. 12 indexed citations

Bergmann, Thorsten, Simone Merlin, Cristina Olgasi, et al.. (2020). Regulatory-Compliant Validation of a Highly Sensitive qPCR for Biodistribution Assessment of Hemophilia A Patient Cells. Molecular Therapy — Methods & Clinical Development. 18. 176–188. 4 indexed citations

Kreß, Sebastian, Johannes Baur, Christoph Otto, et al.. (2018). Evaluation of a Miniaturized Biologically Vascularized Scaffold in vitro and in vivo. Scientific Reports. 8(1). 4719–4719. 17 indexed citations

Mattei, G., Chiara Magliaro, Serena Giusti, et al.. (2017). On the adhesion-cohesion balance and oxygen consumption characteristics of liver organoids. PLoS ONE. 12(3). e0173206–e0173206. 32 indexed citations

Heinz, Stefan, Shahrouz Ghafoory, Stefan Wölfl, et al.. (2015). In Vitro Generation of Functional Liver Organoid-Like Structures Using Adult Human Cells. PLoS ONE. 10(10). e0139345–e0139345. 79 indexed citations

Levy, Gahl, David Bomze, Stefan Heinz, et al.. (2015). Long-term culture and expansion of primary human hepatocytes. Nature Biotechnology. 33(12). 1264–1271. 113 indexed citations

Klieber, Sylvie, et al.. (2015). Applicability of second‐generation upcyte^® human hepatocytes for use in CYP inhibition and induction studies. Pharmacology Research & Perspectives. 3(5). e00161–e00161. 26 indexed citations

Heinz, Stefan & Joris Braspenning. (2014). Measurement of Blood Coagulation Factor Synthesis in Cultures of Human Hepatocytes. Methods in molecular biology. 1250. 309–316. 29 indexed citations

Heinz, Stefan, et al.. (2013). Optimization of upcyte® human hepatocytes for the in vitro micronucleus assay. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 758(1-2). 69–79. 19 indexed citations

10.

Braspenning, Joris, et al.. (2012). Upcyte ^® Microvascular Endothelial Cells Repopulate Decellularized Scaffold. Tissue Engineering Part C Methods. 19(1). 57–67. 16 indexed citations

11.

Heinz, Stefan, Anne Zutavern, Vera Sonntag-Buck, et al.. (2012). Generation of proliferating human hepatocytes using upcyte^®technology: characterisation and applications in induction and cytotoxicity assays. Xenobiotica. 42(10). 939–956. 55 indexed citations

12.

Borchers, Andrea T., Joris Braspenning, Joost M. Meijer, et al.. (1999). E7-specific cytotoxic T cell tolerance in HPV-transgenic mice. Archives of Virology. 144(8). 1539–1556. 22 indexed citations

13.

Braspenning, Joris, et al.. (1998). Secretion of Heterologous Proteins fromSchizosaccharomyces pombeUsing the Homologous Leader Sequence ofpho1+ Acid Phosphatase. Biochemical and Biophysical Research Communications. 245(1). 166–171. 12 indexed citations

14.

Braspenning, Joris, Antonio Marchini, Valentina Albarani, et al.. (1998). The CXXC Zn binding motifs of the human papillomavirus type 16 E7 oncoprotein are not required for its in vitro transforming activity in rodent cells. Oncogene. 16(8). 1085–1089. 10 indexed citations

15.

Zumbach, Klaus, Joris Braspenning, Martin Scheffner, et al.. (1998). Antibodies against Early Proteins of Human Papillomaviruses as Diagnostic Markers for Invasive Cervical Cancer. Journal of Clinical Microbiology. 36(2). 475–480. 102 indexed citations

16.

Müller, Martin, Jian Zhou, Alexander Bürger, et al.. (1997). Chimeric Papillomavirus-like Particles. Virology. 234(1). 93–111. 150 indexed citations

17.

Osen, Wolfram, Stefan Faath, I Hilgert, et al.. (1997). Priming of cytotoxic T lymphocytes by five heat‐aggregated antigens in vivo: Conditions, efficiency, and relation to antibody responses. European Journal of Immunology. 27(9). 2391–2399. 69 indexed citations

18.

Зацепина, О. В., Joris Braspenning, D L Robberson, et al.. (1997). The human papillomavirus type 16 E7 protein is associated with the nucleolus in mammalian and yeast cells. Oncogene. 14(10). 1137–1145. 29 indexed citations

19.

Braspenning, Joris, et al.. (1997). A General Purification Protocol for E7 Proteins from “High- and Low-Risk” Human Papillomavirus Types Expressed in the YeastSchizosaccharomyces pombe. Protein Expression and Purification. 10(2). 192–201. 16 indexed citations

20.

Spitkovsky, Dimitry, et al.. (1996). p53-independent growth regulation of cervical cancer cells by the papillomavirus E6 oncogene.. PubMed. 13(5). 1027–35. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact